1. Home
  2. STGW vs VERA Comparison

STGW vs VERA Comparison

Compare STGW & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

SELL

Current Price

$8.98

Market Cap

1.8B

Sector

N/A

ML Signal

SELL

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$27.79

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
VERA
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
STGW
VERA
Price
$8.98
$27.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$10.71
★ $74.20
AVG Volume (30 Days)
1.4M
★ 1.9M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,909,000,000.00
N/A
Revenue This Year
$11.55
N/A
Revenue Next Year
$2.84
$863.11
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.39
N/A
52 Week Low
$4.29
$23.05
52 Week High
$9.64
$56.05

Technical Indicators

Market Signals
Indicator
STGW
VERA
Relative Strength Index (RSI) 58.00 35.26
Support Level $8.05 N/A
Resistance Level $9.55 $36.95
Average True Range (ATR) 0.31 1.35
MACD 0.07 -0.41
Stochastic Oscillator 56.15 19.84

Price Performance

Historical Comparison
STGW
VERA

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: